Medtronic, Inc.: Competitor’s Strategic Audit, A Case Study

Alicia J. Bajada, Angelo A. Camillo, Akhtiara Erskine and Svetlana Holt

Chapter Chapter 22 in Global Enterprise Management, 2015, pp 153-169 from Palgrave Macmillan

Abstract: Abstract With a mission to alleviate pain and restore patients to full health, Medtronic, Inc., created in 1949, produces a wide range of medical equipment to treat chronic diseases such as heart failure, diabetes, and Parkinson’s disease. Following its creation, Medtronic had significant growth and expansion in Europe, Africa, Canada, Cuba, and Australia. However, in 1962 the company found itself on the verge of bankruptcy. Fortunately, it was able to receive a cash infusion by a capital firm, which helped turn the company around. By 1977, the company was selling in over 70 countries. From 1985 to 2006 it had a dynamic compounded growth rate of 18 percent. Again, the success did not last, and in early 2010 the company’s stock value plummeted. In June of 2011, Omar Ishrak was hired as the new CEO to turn the company around.

Keywords: Business Model Innovation; Employee Engagement; Reverse Innovation; General Electric Healthcare; Medical Device Industry (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-137-51070-9_10

Ordering information: This item can be ordered from
http://www.palgrave.com/9781137510709

DOI: 10.1057/9781137510709_10

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().